1. Rousselet F. et Clenet M. (1972): étude d’un nouvel hypolipémiant, le bis(hydroxy-ethyl-thio)l — 10 décane: le LL 1558 ; II : étude métabolique. Thérapie,27, 413–422.
2. Sirtori M., Montanari G., Gianfranceschi G., Malacrida M.G., Battistin P., Morazzoni G., Tremoli E., Colli S., Maderna P. and Sirtori C. (1983): Clofibrate and tiadenol treatment in hyperlipoproteinemias. Atherosclerosis,49, 149–161.
3. Baggio G., Briani G., Fellin R., Martini S., Baiocchi M.R. and Crepaldi G. (1979): Effect of tiadenol on the concentration and composition of serum lipoproteins in familial hypercholesterolemia. Artery,5, 486–494.
4. Tse F.L.S. and Happy J.M. (1982): Comparative pharmacokinetics of14C-tiadenol in the rat and the dog. Internal files from Sandoz (Hannover, USA).
5. Mounie J., Goudonnet H., Bereksi-Reguig K., Escousse A. et Truchot R. (1983): Effets inducteurs du bis(hydroxyethylthio)-l,10-décane (tiadenol) sur les enzymes microsomales hépatiques chez le rat. J. Pharmacol. Paris,14, 171–182.